Cipla acquires Ivia Beaute’s cosmetics and personal care business for Rs 130 crore

Cipla, a leading pharmaceutical company, has made a significant move into the beauty and personal care sector with the announcement of its acquisition of Ivia Beaute’s cosmetics and personal care business for Rs 130 crore. The deal, signed by Cipla Health Limited (CHL), includes the distribution and marketing business of Ivia Beaute, along with its popular brands Astaberry, Ikin, and Bhimsaini on a global scale.

The transaction is expected to be completed within 60 days from the signing of the agreement, subject to the fulfillment of certain conditions. This strategic acquisition aligns with CHL’s goal of expanding its presence in the fast-growing beauty and personal care market, particularly in Tier 2-6 towns in India.

Astaberry, with a brand legacy of over 16 years, offers a wide range of skincare products that cater to the diverse needs of consumers. The addition of Astaberry, Ikin, and Bhimsaini to CHL’s portfolio will enhance its offerings in the skincare segment, providing consumers with trusted and effective solutions.

Shivam Puri, CEO and Whole Time Director of CHL, expressed excitement about the acquisition, stating that it strengthens the company’s foothold in the beauty and personal care sector and complements its existing product offerings. The move is expected to empower CHL to deliver comprehensive solutions that meet the evolving needs of consumers across different segments.

With the growing demand for beauty and personal care products in Indian households, Cipla’s acquisition of Ivia Beaute’s business signifies a strategic step towards capturing a larger share of this lucrative market. This development is poised to drive further growth and innovation within CHL’s consumer healthcare division.